Several IHC antibodies can be used to help distinguish melanoma from other poorly differentiated tumors, and MLANA, PNL2, TRP-1, and TRP-2 are highly sensitive and 100% specific for the diagnosis of canine oral anaplastic melanocytic tumors [37]. This evidence concerns the gene DCT and melanoma.